drugset / Trial / NCT04099927

A Study of SHR4010 in Patients With Hemodialysis

NCT04099927

Phase 1 Completed 12 enrolled Jiangsu HengRui Medicine Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

The study is being conducted to evaluate the safety and pharmacokinetics of SHR0410 in patients with hemodialysis.

Timeline

Start
2019-07-28
Primary completion
2020-04-20
Completion
2020-06-15

Drugs

EvaluationDrugModalityDoseRoute
Subject SHR0410 Unknown Intravenous

Indications

No indication recorded.